NIH-funded research U01 cooperative agreement

Cannabidiol to reduce opioid use after knee replacement surgery

Official title: Cannabidiol for postoperative Opioid Reduction in primary total Knee arthroplasty – a randomized, 2x2 factorial, double-blind, placebo-controlled clinical trial (The CORK trial)

Funded at University of Michigan at Ann Arbor · NIH-11401961 · Data updated 2026-11-12

A clinical trial tests whether CBD can help lower opioid needs after knee replacement without extra side effects.

More Total Knee Arthroplasty research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startSeptember 18, 2023
Project endAugust 31, 2028
Funding year2026
Award (this year)$1,162,079
NIH project number5U01AR083132-04
Project IDNIH-11401961 on NIH RePORTER

Who could benefit from this research

Could help

Adults undergoing total knee arthroplasty who consent to participate in a randomized trial.

Less likely to help

Some patients may not experience reduced opioid needs or may have adverse reactions to CBD.

What this research studies

Patients undergoing knee replacement are given cannabidiol or placebo in a rigorous, double-blind setup to see if CBD can reduce the amount of opioids they need for pain after surgery. The study uses a 2x2 design to compare CBD vs placebo and different pain-relief regimens, aiming to minimize opioid-related side effects. If CBD proves helpful, it could offer a safer way to manage pain and improve recovery after knee surgery.

Why it matters

Potential benefit: If successful, CBD could reduce opioid use after knee replacement and lessen side effects, improving recovery.

How similar studies have gone: Previous research suggests CBD may help with pain and anxiety, but high-quality trials in postoperative settings are limited.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Brummett, Chad M — University of Michigan at Ann Arbor
  • Study coordinator: Brummett, Chad M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.